'Liquid biopsy market' presentation slideshows

Liquid Biopsy Market to be US$ 3.4 Billion by 2024

Access Full Research: https://www.renub.com/liquid-biopsy-market-p.php As per Renub Research analysis Liquid Biopsy Market is projected to exceed US$ 3.4 Billion by the year 2024, witnessing the worldwide increasing prevalence of cancer and raising awareness regarding the minimal invasive liquid biopsy technology across the world. Today, liquid biopsy has paved the road of cancer diagnosis and treatment by offering a complete treatment response in real time without the need of serial traditional (solid-tissue) biopsies. Today, the population across the globe is growing and aging and so is the global burden of cancer; it is estimated that by the year 2030, the global cancer burden will reach nearly 21.7 Million new cancer cases and be around 13 Million cancer deaths. It is also expected that the low and middle income countries accounts for 60% of the cancer deaths due to the lack of medical resources and proper healthcare systems.

253 views • 14 slides

Liquid Biopsy Market is projected to surpass US$ 3.4 Billion by 2024

187 views • 14 slides

Liquid Biopsy Market Projected to Reach 1.66 Billion USD by 2021

The liquid biopsy market is expected to reach USD 1.66 Billion by 2021 from USD 0.58 Billion in 2016, growing at a CAGR of 23.4% during the forecast period of 2016 to 2021.

259 views • 12 slides

Liquid Biopsy Market

Global liquid biopsy market size, share, market intelligence, company profiles, market trends, growth, potential, segmentation, research and analysis report, forecast 2018-2023

106 views • 9 slides

Liquid Biopsy Market

Global liquid biopsy market size, share, market intelligence, company profiles, market trends, growth, potential, segmentation, research and analysis report, forecast 2018-2023

97 views • 9 slides

Global Biomarker Technologies Market, Forecast to 2022

The vital factors aiding the expansion of this market embrace the increasing utility of biomarkers for diagnostic functions and new initiatives for biomarker analysis. The biomarker technologies market is predicted to achieve USD 74.51 billion in 2022, at a CAGR of 9.7% throughout the forecast period. The main target on biomarker analysis within the field of genetic science is growing with the arrival of innovative technologies.

77 views • 7 slides